Company: TGE
Filing Date: 2025-01-27
Form Type: 425
Source: 0001213900-25-006756
Chunk: 43

Company: Generation Essentials Group
Filing Date: 2025-01-27
Form: 425
Chunk 43
---

any restriction on the right to vote, sell or otherwise dispose of such Pre-Recapitalization Company Shares), and are not subject to any
preemptive rights, rights of first refusal or similar rights, other than generally applicable transfer restrictions imposed by applicable
securities laws. Section 5.06(a) of the Company Disclosure Schedule sets forth a true, correct and complete list, as of the
date of this Agreement, of all the Pre-Recapitalization Company Shares that are authorized, issued or outstanding and the holders of such
Pre-Recapitalization Company Shares. Except as set forth in Section 5.06(a) of the Company Disclosure Schedule, there are no
authorized, issued or outstanding Equity Securities of the Company. The Company Exchange Shares that will be issued pursuant to the Transactions
and the Company Class A Ordinary Shares that will be issued pursuant to the Recapitalization, have been, or will be prior to such
issuance, duly authorized and validly issued in accordance with Applicable Law, including all applicable federal securities laws, and
the Governing Documents of the Company, and are, or will be, fully paid and were not, and will not be, issued in violation of, any preemptive
rights, rights of first refusal or similar rights, and are, and will be at the time of issuance, free and clear of all Liens and other
restrictions (including any restriction on the right to vote, sell or otherwise dispose of such Company Exchange Shares or Company Class A
Ordinary Shares, as applicable, except for any restriction under this Agreement or any of the Ancillary Agreements), and are not, and
will not be, subject to any preemptive rights, rights of first refusal or similar rights, other than under this Agreement or any of the
Ancillary Agreements and generally applicable transfer restrictions imposed by applicable securities laws.

<div align='center'>34</div>

(b) Set
forth on Section 5.06(b) of the Company Disclosure Schedule is (i) the capitalization of each direct and indirect Subsidiary
of the Company, including the number of Equity Securities authorized, issued and outstanding (including the holder of any such Equity
Securities) for each such Subsidiary and (ii) the name of each other corporation, limited liability company, trust, partnership,
joint venture or other entity in which the Company or any of its Subsidiaries owns Equity Securities and the amount and the ownership